William Summers
Gynecology · Birmingham, ALNPI 1811925241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Novo Nordisk accounts for 64.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $794 and has fallen 85.4% since, to $116 in 2025.
Across 165 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Vivus LLC$245
- Eisai Inc.$173
- Astellas Pharma US Inc$161
- Currax Pharmaceuticals LLC$106
- Corcept Therapeutics$70
- plus $282 from 10 others
Across 58 payments — averaging $2883.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organon$115K
- Amgen$33K
- AbbVie$19K
What the payments were for
- Food & beverage$2,84499%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 95 | $1,846 |
| Vivus LLC | 15 | $245 |
| Eisai Inc. | 26 | $173 |
| Astellas Pharma US Inc | 4 | $161 |
| Currax Pharmaceuticals LLC | 7 | $106 |
| Corcept Therapeutics | 3 | $70 |
| BD | 2 | $66 |
| Lilly USA, LLC | 3 | $63 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Nalpropion Pharmaceuticals LLC | 2 | $27 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Scynexis, Inc. | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,883 in reported general payments places this provider in the 85th percentile of 51 gynecology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 121 | $130,536 |
| OzempicSemaglutide | 30 | $43,299 |
| VeozahFezolinetant | 11 | $5,950 |
| Estradiol | 72 | $1,219 |
| Fluconazole | 34 | $313 |
| Metformin Hcl | 36 | $206 |
| Nystatin | 12 | $187 |
| Metronidazole | 17 | $127 |
| Topiramate | 24 | $111 |
| Ondansetron Hcl | 16 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $63 | $130,536121 claims |
| Novo NordiskOzempic | $1,846 | $43,29930 claims |
| Astellas Pharma US IncVeozah | $161 | $5,95011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 51 gynecology providers in Alabama.
Other gynecology in Birmingham
- Holly RichterBirmingham$22K
- Alex ChildsBirmingham$9K
- Gena DunivanBirmingham$7K
- Katelyn DonaldsonBirmingham$1K
- Martha CoghlanBirmingham$801
- Earl StradtmanBirmingham$131
- James UpchurchBirmingham$130
- Craig ChristopherBirmingham$34
- Dee DensonBirmingham$19
- Alicia BallardBirmingham$16
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.